NKTR Section 144: 180 Shares Registered for Resale

NKTR files a Section 144 notice to sell 180 common shares related to restricted stock vesting dated 02/13/2026.

Rhea-AI Filing Summary

NKTR files a Section 144 notice to sell 180 common shares related to restricted stock vesting dated 02/13/2026. The filing lists a proposed sale of 180 shares by Fidelity Brokerage Services LLC.

The excerpt also records prior sales by Jonathan Zalevsky: 1,157 shares sold on 11/25/2025 and 3,867 shares sold on 01/20/2026, with corresponding dollar amounts shown in the table.

Insights

Securities Compliance Counsel

Section 144 notice documents a proposed resale of 180 restricted shares vesting on 02/13/2026.

This filing records a broker-affiliated holder, Fidelity Brokerage Services LLC, as the conduit for 180 common shares arising from restricted stock vesting. The notice is a routine disclosure under the securities resale rules.

Timing and execution methods for the resale are not included in the excerpt; subsequent filings or trade reports would show actual sales activity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NKTR Form 144 filing disclose?

The filing discloses a proposed resale of 180 common shares associated with restricted stock vesting on 02/13/2026. It lists the selling conduit as Fidelity Brokerage Services LLC and shows prior sales by Jonathan Zalevsky on specific dates.

Who is listed as the selling holder in the NKTR excerpt?

The excerpt lists Fidelity Brokerage Services LLC at 900 Salem Street as the selling broker for 180 common shares tied to restricted stock vesting dated 02/13/2026. Additional prior sales list Jonathan Zalevsky.

What prior transactions are shown in the NKTR excerpt?

The excerpt shows two prior sales by Jonathan Zalevsky: 1,157 shares sold on 11/25/2025 and 3,867 shares sold on 01/20/2026. Dollar amounts associated with those rows are included in the table.

Does the Form 144 excerpt state when the shares will be sold?

The excerpt specifies the vesting date of the registered shares as 02/13/2026 but does not provide execution timing or sale methods. Actual sale dates and methods are not included in the provided text.

Does the NKTR filing indicate who receives proceeds from the sale?

The excerpt identifies the securities as arising from restricted stock vesting and lists the selling broker, but it does not state the recipient of proceeds or how proceeds will be treated in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 03:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789857
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEKTAR THERAPEUTICS
SEC File Number	000-24006
Address of Issuer	455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CALIFORNIA 94158
Phone	4154825300
Name of Person for Whose Account the Securities are To Be Sold	Zalevsky Jonathan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	180	13139.68	20341589	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			180	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Zalevsky 455 Mission Bay Boulevard South San Francisco CA 94158	Common	11/25/2025	1157	68052.89
Jonathan Zalevsky 455 Mission Bay Boulevard South San Francisco CA 94158	Common	01/20/2026	3867	137946.37

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan Zalevsky
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)